How can the EU’s pharmaceutical legislation help tackle current challenges, including medicine shortages and antimicrobial resistance, across Europe? We put the question to Rainer Becker, Director for Medical Products and Innovation at DG SANTE.
New research explores the link between ethnicity and ESKD, which finds that Afro-Caribbean patients are four times more likely to undergo COVID hospitalisation.
Eight days after the Pfizer vaccine results (90% effective) brought collective hope to the world, the Moderna vaccine has proven to be 95% effective at fighting COVID-19.
Over 350 million people suffer from arthritis pain globally, which means significant levels of opiates are used to manage the condition - but what if there was a less addictive treatment?
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
Though heart damage plays a role in how someone deals with COVID-19, researchers at the American Heart Association found that blood pressure medicines don't impact your chances.
US health insurance coverage decreased significantly, resulting in 25,180 excess deaths before COVID - researchers say this number will triple if the Affordable Care Act is overturned.
Craig Hartley, UK Business Development Manager for OPEX Business Machines GmbH explains how their solutions are helping both the NHS and the wider Public Sector achieve digital transformation.
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
Emmanouil Avgerinos, Ioannis Fragkos and Yufei Huang explain that for surgical teams, shared experiences and hierarchical structures matter more than you think.
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.
